Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BY 4.0Nutrients

Integrative Proteomics Reveals That Ejiao Alleviates Premature Ovarian Insufficiency and Restores Bone Metabolism in Mice

  1. 1Marine Biomedical Research Institute of Qingdao, Qingdao 266701, China
  2. 2Shandong Key Laboratory of Gelatine Medicines Research and Development, Dong’e Ejiao Co., Ltd., No. 78, E-Jiao Street, Done-E Country, Liaocheng 252200, China
  3. 3State Key Laboratory of Marine Food Processing & Safety Control, College of Food Science and Engineering, Ocean University of China, Qingdao 266000, China

Abstract

Background: Premature ovarian insufficiency (POI) is an intractable reproductive endocrine disease characterized by accelerated ovarian aging, accelerated follicle depletion and hormonal disorders, leading to secondary bone metabolic dysfunction and impaired long-term female health. Conventional hormone replacement therapy is the guideline-recommended first-line therapy for young women with POI, yet its long-term safety must be individualized; natural nutritional interventions are best viewed as complementary strategies. Donkey-hide gelatin (Ejiao), a natural food rich in bioactive collagen and amino acids, is commonly used for female reproductive care. Nevertheless, its systematic efficacy and molecular mechanisms against POI and related bone complications remain poorly defined. Methods: This study established a tripterygium glycosides (TG)-induced POI mouse model. Mice received low-dose (1.5 g/kg) and high-dose (3.0 g/kg) Ejiao treatment for 30 consecutive days. Reproductive organ morphology, estrous cycle, serum hormone levels, ovarian histopathology, bone microarchitecture and ovarian proteomic profiles were assessed. Results: Ejiao remarkably restored ovarian index and tended to improve uterine index (non-significant), corrected estrous cycle disturbance, and partially corrected the endocrine profile (E2, AMH, GnRH). It upregulated the ovarian reserve markers E2 and AMH and downregulated GnRH. Histological examination verified improved follicular development and reduced atresia. Furthermore, Ejiao alleviated POI-induced bone loss, optimized trabecular microstructure and rescued abnormal RANKL/OPG ratio to stabilize bone metabolism. Proteomic analysis revealed 313 differentially expressed proteins (DEPs) between Ejiao-treated and model groups, with enrichment in calcium signaling, cAMP, cGMP-PKG, and TGF-β/Smad pathways. Conclusions: As a natural bioactive food, Ejiao exerts dual protective effects against POI and concurrent bone metabolic dysfunction associated with modulation of multiple core signaling pathways and functional proteins (suggesting involvement of these pathways in its effects).

Related

  1. Restoring fertility in premature ovarian insufficiency: Targeting the ovarian stroma with antifibrotic drugs
    Yu Zhao, Kui Liu
    Clinical and Translational MedicinePeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  2. Screening traditional Chinese medicine monomers for premature ovarian insufficiency: from network meta-analysis to the effects of a promising candidate on oxidative stress biomarkers
    Yanping Tan, Mei Zhao, Lianwei Xu
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  3. Mitigating Environmental Pollutant-Induced Premature Ovarian Insufficiency by Rationally Designed Ultrasmall Gold Nanoparticles via Dual Regulation of ROS and Mitophagy.
    Liyuan Xue, Kai Cao, Mingyang Du +5
    Environment & health (Washington, D.C.)Peer-reviewedCC BY-NC-NDFull text1 citedEpidemiology & public healthEurope PMC
  4. Genetics of Premature Ovarian Insufficiency: From Molecular Architecture to Precision Medicine.
    Vanessa Sousa, Gabriel Livera, Micheline Misrahi
    International journal of molecular sciencesPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  5. Nrf2-related pathogenesis of premature ovarian insufficiency and traditional Chinese medicine-based interventions
    Lan Li, Xinwu Zheng, Meiqiao Wang +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
BibTeX
@article{wang2026integrative,
  title = {{Integrative Proteomics Reveals That Ejiao Alleviates Premature Ovarian Insufficiency and Restores Bone Metabolism in Mice}},
  author = {Changwei Wang and Xueyuan Fu and Qin Feng and Wanxiu Cao and Fen Du and Chuyi Liu and Xiaomei Feng and Shan Liu and Hu Hou and Bafang Li and Xiaoying Zhou},
  journal = {Nutrients},
  year = {2026},
  month = oct,
  doi = {10.3390/nu18213595},
  url = {https://www.mdpi.com/2072-6643/18/21/3595},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Integrative Proteomics Reveals That Ejiao Alleviates Premature Ovarian Insufficiency and Restores Bone Metabolism in Mice
AU  - Changwei Wang
AU  - Xueyuan Fu
AU  - Qin Feng
AU  - Wanxiu Cao
AU  - Fen Du
AU  - Chuyi Liu
AU  - Xiaomei Feng
AU  - Shan Liu
AU  - Hu Hou
AU  - Bafang Li
AU  - Xiaoying Zhou
PY  - 2026
DA  - 2026/10/29
JO  - Nutrients
DO  - 10.3390/nu18213595
UR  - https://www.mdpi.com/2072-6643/18/21/3595
AB  - Background: Premature ovarian insufficiency (POI) is an intractable reproductive endocrine disease characterized by accelerated ovarian aging, accelerated follicle depletion and hormonal disorders, leading to secondary bone metabolic dysfunction and impaired long-term female health. Conventional hormone replacement therapy is the guideline-recommended first-line therapy for young women with POI, yet its long-term safety must be individualized; natural nutritional interventions are best viewed as complementary strategies. Donkey-hide gelatin (Ejiao), a natural food rich in bioactive collagen and amino acids, is commonly used for female reproductive care. Nevertheless, its systematic efficacy and molecular mechanisms against POI and related bone complications remain poorly defined. Methods: This study established a tripterygium glycosides (TG)-induced POI mouse model. Mice received low-dose (1.5 g/kg) and high-dose (3.0 g/kg) Ejiao treatment for 30 consecutive days. Reproductive organ morphology, estrous cycle, serum hormone levels, ovarian histopathology, bone microarchitecture and ovarian proteomic profiles were assessed. Results: Ejiao remarkably restored ovarian index and tended to improve uterine index (non-significant), corrected estrous cycle disturbance, and partially corrected the endocrine profile (E2, AMH, GnRH). It upregulated the ovarian reserve markers E2 and AMH and downregulated GnRH. Histological examination verified improved follicular development and reduced atresia. Furthermore, Ejiao alleviated POI-induced bone loss, optimized trabecular microstructure and rescued abnormal RANKL/OPG ratio to stabilize bone metabolism. Proteomic analysis revealed 313 differentially expressed proteins (DEPs) between Ejiao-treated and model groups, with enrichment in calcium signaling, cAMP, cGMP-PKG, and TGF-β/Smad pathways. Conclusions: As a natural bioactive food, Ejiao exerts dual protective effects against POI and concurrent bone metabolic dysfunction associated with modulation of multiple core signaling pathways and functional proteins (suggesting involvement of these pathways in its effects).
SN  - 2072-6643
ER  -